Psychiatry and Neurology, Neurology · Newport Beach, CA
NPI
1720187487
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3900 W Coast Hwy, Suite 330
Newport Beach, CA, 92663
Phone (949) 759-8001
Groups this clinician bills Medicare through
Medicare paid, 2024
$708K
110,025 services
Medicare patients, 2024
451
Average age 74
Drug cost, 2024
$3.1M
9,584 prescriptions
Company payments, 2025
$47K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher P O'Carroll was code J0585 (injection, onabotulinumtoxina, 1 unit), 108,500 times for 169 patients. In total Christopher P O'Carroll billed 110,025 services in 9 codes, and Medicare paid $708K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-22.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 108,500 | 169 | $4.91 | $533K |
| 99214 Office E&M - Established | Office | 450 | 204 | $106.05 | $48K |
| 64615 Musculoskeletal | Office | 449 | 139 | $128.58 | $58K |
| 99205 Office E&M - New | Office | 156 | 156 | $184.36 | $29K |
| 99215 Office E&M - Established | Office | 103 | 86 | $149.16 | $15K |
| 64616 Musculoskeletal | Office | 68 | 26 | $117.40 | $7,983 |
By year: 2022 $643K for 98,552 services; 2023 $658K for 100,363 services; 2024 $708K for 110,025 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher P O'Carroll prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 479 prescriptions and refills. In total Christopher P O'Carroll wrote 9,584 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 479 | 479 | 67 | $11K |
| Sumatriptan Succinate Generic | 455 | 558 | 80 | $24K |
| Gabapentin Generic | 432 | 650 | 87 | $5,561 |
| Clonazepam Generic | 415 | 538 | 93 | $3,420 |
| Oxycodone Hcl Generic | 296 | 296 | 37 | $6,528 |
| Alprazolam Generic | 265 | 275 | 61 | $1,184 |
| Lorazepam Generic | 260 | 268 | 39 | $1,550 |
| Rizatriptan Rizatriptan Benzoate | 255 | 281 | 45 | $6,239 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 244 | 254 | 47 | $5,606 |
| Duloxetine Hcl Generic | 235 | 361 | 36 | $3,156 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 230 | 230 | 40 | $5,921 |
| Zolpidem Tartrate Generic | 211 | 241 | 45 | $2,701 |
| Emgality Pen Galcanezumab-Gnlm | 204 | 226 | 30 | $153K |
| Escitalopram Oxalate Generic | 183 | 321 | 36 | $1,959 |
| Spravato Esketamine Hcl | 160 | 160 | Under 11 | $205K |
Brand drugs: - claims; generic drugs: 7,821 claims; opioid claims: 1,739.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher P O'Carroll $47K ($47K in general payments such as food, travel and fees) from 27 companies. The largest payer was Axsome Therapeutics, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 32 | $21K |
| Pfizer Inc. PFE | 34 | $9,069 |
| Abbvie Inc. ABBV | 91 | $7,455 |
| Lundbeck LLC | 13 | $6,140 |
| UCB, Inc. UCB.BR | 27 | $708 |
| Alexion Pharmaceuticals, Inc. AZN | 12 | $331 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $254 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $233 |
| LivaNova USA, Inc. LIVN | 4 | $223 |
| Eisai Inc. 4523.T | 7 | $153 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.